Humana Expands Use of the Inovalon ONE® Platform
March 22 2021 - 7:55AM
Inovalon (Nasdaq: INOV), a leading provider of
cloud-based platforms empowering data-driven healthcare, and
Humana (NYSE: HUM), a leading national consumer-focused,
technology-driven health plan known for its commitment to
innovation, today announced the expansion of their collaboration in
a focus on vaccine adherence.
Under the engagement, Inovalon will implement
the Inovalon ONE® Platform Vaccine Adherence Program, leveraging
established healthcare ecosystem connectivity, data integration,
normalization, and analyses to assess clinical applicability and
adherence of health plan members to applicable Centers for Disease
Control and Prevention (CDC) Advisory Committee on Immunization
Practices (ACIP) immunization schedules and guidelines. Analytical
insights delivered through the data-driven program will inform
member engagement and disease education efforts to promote
uptake of recommended vaccines, resulting in improved health
outcomes, quality ratings and overall public health, as well
as significant economic benefits stemming from reductions
in vaccine-preventable disease incidence and associated
treatment costs.
The broader Inovalon and Humana engagement dates
back to early 2019 with the implementation of a configuration of
the Inovalon ONE® Platform focused on achieving advanced insight
into member conditions and the subsequent empowering of data-driven
initiatives to benefit Humana’s Commercial membership. A leading
specialty pharmacy operator, Humana expanded the relationship later
in 2019 to include Inovalon’s ScriptMed® Cloud offering, a
configuration of the Inovalon ONE® Platform designed to combine
superior analytically driven care protocols with superior quality,
operational processes, and cost efficiencies for pharmacies. In
early 2020, Humana added Inovalon’s Virtual Health Visit
capabilities and later in 2020 expanded the application of the
Inovalon ONE® Platform to Humana’s Medicare membership.
“We are very pleased and appreciative to expand
our relationship with such an industry innovator as Humana,” said
Keith Dunleavy, M.D., chief executive officer of Inovalon.
“Humana’s commitment to their members’ quality of care as well as
their commitment to partnership in progressing programs together
has been remarkable.”
About Inovalon
Inovalon is a leading provider of cloud-based
platforms empowering data-driven healthcare. Through the Inovalon
ONE® Platform, Inovalon brings to the marketplace a national-scale
capability to interconnect with the healthcare ecosystem, aggregate
and analyze data in real time, and empower the application of
resulting insights to drive meaningful impact at the point of care.
Leveraging its Platform, unparalleled proprietary datasets, and
industry-leading subject matter expertise, Inovalon enables better
care, efficiency, and financial performance across the healthcare
ecosystem. From health plans and provider organizations, to
pharmaceutical, medical device, and diagnostics companies,
Inovalon’s unique achievement of value is delivered through the
effective progression of “Turning Data into Insight, and Insight
into Action®.” Supporting thousands of clients, including all 25 of
the top 25 U.S. health plans, 22 of the top 25 global pharma
companies, 19 of the top 25 U.S. healthcare provider systems, and
many of the leading pharmacy organizations, device manufacturers,
and other healthcare industry constituents, Inovalon’s technology
platforms and analytics are informed by data pertaining to more
than one million physicians, 574,000 clinical facilities, 332
million Americans, and 61 billion medical events. For more
information, visit www.inovalon.com.
Contact:
Kim E. Collins Senior Vice President, Corporate
Communicationskcollins@inovalon.com301-809-4000 x1473
Hulus AlpayVice President, Investor
Relationshalpay@inovalon.com301-809-4000 x1237
Humana (NYSE:HUM)
Historical Stock Chart
From Jul 2024 to Aug 2024
Humana (NYSE:HUM)
Historical Stock Chart
From Aug 2023 to Aug 2024